Sanofi India has reported results for the first quarter ended March 31, 2016.
The company has posted a rise of 24.96% in its net profit at Rs 80.60 crore for the quarter ended March 31, 2016 as compared to Rs 64.50 crore for the same quarter in the previous year. Total income of the company has increased by 12.14% at Rs 570.00 crore for quarter under review as compared to Rs 508.30 crore for the quarter ended March 31, 2015.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
